Please login to the form below

Not currently logged in
Email:
Password:

Cirara

This page shows the latest Cirara news and features for those working in and with pharma, biotech and healthcare.

Biogen wins European spinal muscular atrophy first

Biogen wins European spinal muscular atrophy first

To that end it recently bought late-stage stroke candidate Cirara (glyburide) from Remedy Pharma and an anti-tau antibody from Bristol-Myers Squibb for Alzheimer's disease.

Latest news

  • Biogen hands out $120m upfront for Remedy stroke drug Biogen hands out $120m upfront for Remedy stroke drug

    Cirara vying to be first new treatment since the 1990s. Biogen has added to its late-stage pipeline with a licensing deal for Remedy Pharmaceuticals' Cirara, a drug candidate en route ... Cirara (RP-1127) is an intravenous formulation of glyburide, a

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Viseven

Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics